More OncoSil Medical Ltd news
OncoSil Medical LtdASX: OSL

FY 2023 Strategic Update

Jun 29, 2022 at 10:45 PM EDT · Issued by OncoSil Medical Ltd

Filed with ASX · Jun 29, 2022 at 10:45 PM EDT

On 6ix: 6ix.com/news/fy-2023-strategic-update

Oncosil Medical Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

OncoSil Medical Ltd on 6ix

Earlier from OncoSil Medical

  • OncoSil PanCO Clinical Trial Presented At ESMO World WCGICJun 28, 2022
  • Entitlement Offer Results and Shortfall NotificationJun 9, 2022
  • OncoSil Entitlement Offer BookletMay 10, 2022
  • Clarification Of Non-Renouncable Entitlement Offer DetailsMay 1, 2022
  • OncoSil Launches $10m Capital RaisingApr 29, 2022

Later from OncoSil Medical

  • Bupa UK Approves Reimbursement for OncoSil in the UKJul 3, 2022
  • Patient treated in Spain proceeds to successful resectionJul 18, 2022
  • Monthly Activities/Appendix 4C Cash Flow ReportJul 29, 2022
  • Investor PresentationAug 3, 2022
  • Appendix 4E AnnouncementAug 30, 2022
All OncoSil Medical news releases↗

Follow OncoSil Medical into a list and get an email when it puts out news.

Follow OncoSil Medical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer